Skip to content
OpenCapital
Get started

Jaguar Health JAGX Q3 2024 earnings

Reported November 13, 2024 · Before market open

Revenue$3.1MMiss by $832.0K
EPS-$26.25Miss by $23.88
Revenue estimate$3.9M
EPS estimate-$2.37

Next report

Aug 13, 2026 (In 2 weeks)
Revenue estimate$4.2M
EPS estimate-$52.15

Versus estimates

Revenue

Q4 2025$3.2MMiss by $975.0KQ3 2025$3.1MMiss by $647.0KQ2 2025$3.0MMiss by $751.0KQ1 2025$2.2MMiss by $1.1MQ4 2024$3.5MBeat by $379.0K
Q3 2024$3.1MMiss by $832.0K

Diluted EPS

Q4 2025-$13.60Beat by $135.50Q3 2025-$6.28Miss by $1.20Q2 2025-$10.26Miss by $5.18Q1 2025-$16.70Beat by $1.30Q4 2024-$0.34Beat by $18.16
Q3 2024-$26.25Miss by $23.88

Ask the moment Jaguar Health reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Jaguar Health report Q3 2024 earnings?
Jaguar Health (JAGX) reported Q3 2024 earnings on November 13, 2024 before market open.
What were Jaguar Health's Q3 2024 revenue and EPS?
Jaguar Health reported revenue of $3.1M and eps of $-26.25 for Q3 2024.
Did Jaguar Health beat estimates in Q3 2024?
Revenue missed the consensus estimate of $3.9M by $832.0K. EPS missed the consensus estimate of $-2.37 by $23.88.
Where can I find Jaguar Health's Q3 2024 SEC filings?
You can read the 10-Q periodic report (0000950170-24-125916) directly on SEC EDGAR. The filing index links above go to sec.gov.